Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |